Compare ACB & REFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACB | REFI |
|---|---|---|
| Founded | 2013 | 2021 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 164.8M | 241.1M |
| IPO Year | 2016 | 2021 |
| Metric | ACB | REFI |
|---|---|---|
| Price | $3.79 | $10.30 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 157.1K |
| Earning Date | 06-17-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 15.79% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.57 |
| Revenue | N/A | ★ $48,857,628.00 |
| Revenue This Year | $6.31 | $17.47 |
| Revenue Next Year | N/A | $0.06 |
| P/E Ratio | ★ N/A | $18.33 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.56 | $9.69 |
| 52 Week High | $6.67 | $14.57 |
| Indicator | ACB | REFI |
|---|---|---|
| Relative Strength Index (RSI) | 80.18 | 50.28 |
| Support Level | $3.22 | $9.69 |
| Resistance Level | $3.91 | $12.45 |
| Average True Range (ATR) | 0.15 | 0.23 |
| MACD | 0.13 | 0.08 |
| Stochastic Oscillator | 90.73 | 79.27 |
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. The Company operates as one operating segment, and its primary investment objective is to provide attractive, risk-adjusted returns for stockholders over time, mainly through consistent current income (dividends and distributions) and secondarily, through capital appreciation. The company operates mainly within the USA itself.